Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
At close: Oct 20, 2026
Lipella Pharmaceuticals Market Cap
Lipella Pharmaceuticals has a market cap or net worth of $2.31 thousand as of October 20, 2026. It is the 52,254th most valuable company in the world and the 8,265th biggest in the United States. Its market cap has decreased by 99.92% in one year.
Market Cap
2.31K
Enterprise Value
-1.59M
Revenue
389.78K
Global Rank
Country Rank
#8,265 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since December 20, 2022, Lipella Pharmaceuticals's market cap has decreased from 27.05M to 2.31K, a decrease of -99.99%. That is a compound annual growth rate of -91.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 2.31K | -99.72% |
| Dec 31, 2025 | 831.75K | -77.44% |
| Dec 31, 2024 | 3.69M | -37.72% |
| Dec 29, 2023 | 5.92M | -67.07% |
| Dec 30, 2022 | 17.98M | -33.55% |
| Dec 20, 2022 | 27.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Synovics Pharmaceuticals | 3.65K |
| Anthera Pharmaceuticals | 3.53K |
| Affimed | 3.28K |
| Rebus Holdings | 3.21K |
| Hemagen Diagnostics | 3.10K |
| Comera Life Sciences Holdings | 3.07K |
| Innoveren Scientific | 2.40K |
| OncoVista Innovative Therapies | 2.36K |